Pliant Therapeutics, Inc.
PLRX
$1.34
$0.031.91%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.58M | -26.30M | -43.30M | -56.17M | -49.73M |
| Total Depreciation and Amortization | 365.00K | 436.00K | 447.00K | 448.00K | 458.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.46M | 7.53M | 9.17M | 11.09M | 9.79M |
| Change in Net Operating Assets | -2.04M | -2.75M | -6.92M | -4.23M | -8.18M |
| Cash from Operations | -17.79M | -21.08M | -40.60M | -48.86M | -47.66M |
| Capital Expenditure | 0.00 | 0.00 | -112.00K | -262.00K | -209.00K |
| Sale of Property, Plant, and Equipment | -1.00K | 156.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.77M | 27.77M | 35.60M | 69.38M | 39.34M |
| Cash from Investing | 1.77M | 27.92M | 35.49M | 69.11M | 39.13M |
| Total Debt Issued | -- | -- | -- | -- | 1.00K |
| Total Debt Repaid | -32.27M | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 72.00K | 0.00 | 498.00K | 101.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -32.27M | 72.00K | 0.00 | 498.00K | 102.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -48.29M | 6.91M | -5.12M | 20.75M | -8.43M |